These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32813367)

  • 1. Policies affecting the supply and access of opioid analgesics: a scoping review protocol.
    Chiu K; McDonald S; Legg T; Karanges EA; Bero L
    JBI Evid Synth; 2020 May; 18(5):1124-1134. PubMed ID: 32813367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.
    Mauri AI; Townsend TN; Haffajee RL
    Milbank Q; 2020 Mar; 98(1):57-105. PubMed ID: 31800142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies and policies to address the opioid epidemic: A case study of Ohio.
    Penm J; MacKinnon NJ; Boone JM; Ciaccia A; McNamee C; Winstanley EL
    J Am Pharm Assoc (2003); 2017; 57(2S):S148-S153. PubMed ID: 28189539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review.
    Coyle DT; Pratt CY; Ocran-Appiah J; Secora A; Kornegay C; Staffa J
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):464-472. PubMed ID: 29243305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol.
    Jones KF; Malinowski J; Paice J; Childers J; Bulls HW; Morrison J; Ho JJ; Alsbrook K; Nugent S; Broglio K; Nickels K; Holbein M; Parajuli J; Merlin JS
    JBI Evid Synth; 2023 Apr; 21(4):812-825. PubMed ID: 36404752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of the science in opioid policy research.
    Schuler MS; Heins SE; Smart R; Griffin BA; Powell D; Stuart EA; Pardo B; Smucker S; Patrick SW; Pacula RL; Stein BD
    Drug Alcohol Depend; 2020 Sep; 214():108137. PubMed ID: 32652376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal approaches and government policies enacted to address the overdose epidemic: a scoping review protocol.
    Pawliuk C; Park M; Buxton JA;
    JBI Evid Synth; 2021 Jan; 19(1):184-200. PubMed ID: 32813427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.
    Leece P; Khorasheh T; Corace K; Strike C; Bayoumi AM; Taha S; Marks E; Pach B; Ahamad K; Grennell E; Holowaty M; Manson H; Straus SE
    BMJ Open; 2019 Dec; 9(12):e032285. PubMed ID: 31843837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports.
    Crowley D; Homeniuk R; Delargy I
    BMJ Open; 2020 Dec; 10(12):e040556. PubMed ID: 33277286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review.
    Balbale SN; Trivedi I; O'Dwyer LC; McHugh MC; Evans CT; Jordan N; Keefer LA
    Dig Dis Sci; 2017 Oct; 62(10):2668-2685. PubMed ID: 28780607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Opioid Epidemic: Challenge to Military Medicine and National Security.
    Dembek ZF; Chekol T; Wu A
    Mil Med; 2020 Jun; 185(5-6):e662-e667. PubMed ID: 32077961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is known about community pharmacy supply of naloxone? A scoping review.
    Nielsen S; Van Hout MC
    Int J Drug Policy; 2016 Jun; 32():24-33. PubMed ID: 26949189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review.
    Lalic S; Jokanovic N; Ilomäki J; Gisev N; Lloyd B; Lubman DI; Bell JS
    Res Social Adm Pharm; 2019 Aug; 15(8):925-935. PubMed ID: 30076092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of Interventions and Policies on Opioids and Awareness of Opioid-Related Harms in Canada: A Multistage Mixed Methods Descriptive Study.
    Goyer C; Castillon G; Moride Y
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Canadian and United States opioid agonist therapy policies.
    Priest KC; Gorfinkel L; Klimas J; Jones AA; Fairbairn N; McCarty D
    Int J Drug Policy; 2019 Dec; 74():257-265. PubMed ID: 30765118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis.
    Deschamps J; Gilbertson J; Straube S; Dong K; MacMaster FP; Korownyk C; Montgomery L; Mahaffey R; Downar J; Clarke H; Muscedere J; Rittenbach K; Featherstone R; Sebastianski M; Vandermeer B; Lynam D; Magnussen R; Bagshaw SM; Rewa OG
    Syst Rev; 2019 Apr; 8(1):88. PubMed ID: 30953550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of prescription opioid misuse and abuse.
    Strassels SA
    J Manag Care Pharm; 2009 Sep; 15(7):556-62. PubMed ID: 19739878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.